Cancer Therapy Breakthrough: Drug or Medicine?

We have been hoping for breakthrough in the “war on cancer” for long (decades), and we expect it will come one day with the discovery of a “miracle drug”. With time lapsing and repeated showing the same limited effects of new drugs, that expectation is gradually fading. What if the miracle drug does not exist by theory? As this opinion/perspective argues, breakthrough in cancer management does not have to be a drug, it may well come from the science behind using current drugs or treatments. We have been ignoring cancer medicine for long and it is time to bring up our attention to it because it can be demonstrated that using existing means, but with different ways of selecting and using them, we may significantly increase (double or triple) patient survival while significantly decreasing the cost for achieving such goals. If that is not a breakthrough, I don’t know what else is. Thus, all we have to do is to find out ways to bring it to cancer clinics everywhere. The first step is to change our concept and acknowledge its significance. That is the purpose of this writing.

Authors

Publication Details

Journal
Medical & Clinical Research
Published
2024-09-21
DOI
https://doi.org/10.33140/mcr.09.09.01
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer Therapy Breakthrough: Drug or Medicine?

Kangla Tsung
Medical & Clinical Research
PARP inhibition in cancer therapy
article

Cancer Therapy Breakthrough: Drug or Medicine?

Kangla Tsung
article en

Abstract

We have been hoping for breakthrough in the “war on cancer” for long (decades), and we expect it will come one day with the discovery of a “miracle drug”. With time lapsing and repeated showing the same limited effects of new drugs, that expectation is gradually fading. What if the miracle drug does not exist by theory? As this opinion/perspective argues, breakthrough in cancer management does not have to be a drug, it may well come from the science behind using current drugs or treatments. We have been ignoring cancer medicine for long and it is time to bring up our attention to it because it can be demonstrated that using existing means, but with different ways of selecting and using them, we may significantly increase (double or triple) patient survival while significantly decreasing the cost for achieving such goals. If that is not a breakthrough, I don’t know what else is. Thus, all we have to do is to find out ways to bring it to cancer clinics everywhere. The first step is to change our concept and acknowledge its significance. That is the purpose of this writing.

Medical & Clinical ResearchVol. 9(9)
Openalex Percentile: Top 72%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.